Generation of an attenuated H5N1 avian influenza virus vaccine with all eight genes from avian viruses

Vaccine

Volumn 25, Issue 42, 2007, Pages 7379-7384

  Shi, Huoying ^a   Liu, Xiu Fan ^a   Zhang, Xiaorong ^a   Chen, Sujuan ^a   Sun, Lei ^a   Lu, Jianhong ^a  

^a YANGZHOU UNIVERSITY   (China)

Author keywords

Avian influenza virus; Reverse genetics method; Vaccine

Indexed keywords

AMINO ACID; AVIAN INFLUENZA VACCINE; HEMAGGLUTININ; SIALIDASE;

AMNION FLUID; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BIRD DISEASE; CHICKEN; CONTROLLED STUDY; DRUG MECHANISM; DRUG SAFETY; FEMALE; GENE DELETION; GENE MUTATION; GENETIC REASSORTMENT; INFECTION CONTROL; INFLUENZA VIRUS A H5N1; MOUSE; NONHUMAN; PATHOGENICITY; PHENOTYPE; PRIORITY JOURNAL; PROTEIN MOTIF; VIRAL GENETICS; VIRUS ATTENUATION; ZYGOTE;

AMINO ACID SEQUENCE; ANIMALS; BASE SEQUENCE; CHICKENS; DNA, VIRAL; FEMALE; FORMALDEHYDE; GENES, VIRAL; HEMAGGLUTININ GLYCOPROTEINS, INFLUENZA VIRUS; HUMANS; INFLUENZA A VIRUS, H5N1 SUBTYPE; INFLUENZA IN BIRDS; INFLUENZA VACCINES; INFLUENZA, HUMAN; MICE; MICE, INBRED BALB C; VACCINES, ATTENUATED; VACCINES, INACTIVATED; VIRUS REPLICATION;

EID: 34748842746     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2007.08.011     Document Type: Article

References (27)

1. Cox R.J., Brokstad K.A., and Ograz P. Influenza virus: immunity and vaccination strategies. Comparison of the immune response to inactivated and live, attenuated influenza vaccines. Scand J Immunol 59 (2004) 1-15
2. Subbarao K., Klimov A., Katz J., Regnery H., Lim W., Hall H., et al. Characterization of an avian influenza A (H5N1) virus isolated from a child with a fatal respiratory illness. Science 279 (1998) 393-396
3. Subbarao K., and Shaw M.W. Molecular aspects of avian influenza (H5N1) viruses isolated from humans. Rev Med Virol 10 (2000) 337-338
4. Mounts A.W., Kwong H., Izurieta H.S., Ho Y., Au T., Lee M., et al. Case control study of risk factors for avian influenza A (H5N1) disease, Hong Kong, 1997. J Infect Dis 180 (1999) 505-508
5. Cauthen A.N., Swayne D.E., Schultz C.S., Perdue M.L., and Suarez D.L. Continued circulation in China of highly pathogenic avian influenza viruses encoding the hemagglutinin gene associated with the 1997 H5N1 outbreak in poultry and humans. J Virol 74 (2000) 6592-6599
6. Bartlett J.G. Planning for avian influenza. Ann Intern Med 145 2 (2006) 141-154
7. Palese P., and García-Sastre A. Influenza vaccines: present and future. Clin Invest 110 (2002) 9-13
8. Subbarao K., Chen H.L., Swayne D., Mingay L., Fodor E., Brownlee G.G., et al. Evaluation of a genetically modified reassortant H5N1 influenza A virus vaccine candidate generated by plasmid-based reverse genetics. Virology 305 (2003) 192-200
9. Hoffmann E., Krauss S., Perez D., Webby R., and Webster R.G. Eight-plasmid system for rapid generation of influenza virus vaccines. Vaccine 20 25-26 (2002) 3165-3170
10. Hoffmann E., Mahmood K., Yang C.F., Webster R.G., Greenberg H.B., and Kemble FG. Rescue of influenza B virus from eight plasmids. Proc Natl Acad Sci USA 99 17 (2002) 11411-11416
11. Lu J.H., Liu X.F., Shao W.X., Liu Y.L., Wei D.P., and Liu H.Q. Phylogenetic analysis of eight genes of h9n2 subtype influenza virus: a Mainland China strain possessing early isolates' genes that have been circulating. Virus Genes 31 2 (2005) 163-169
12. Hoffmann E., Stech J., Guan Y., Webster R.G., and Perez D.R. Universal primer set for the full-length amplification of all influenza A viruses. Arch Virol 46 12 (2001) 2275-2289
13. Hoffmann E., Neumann G., Kawaoka Y., Hobom G., and Webster R.G. A DNA transfection system for generation of influenza A virus from eight plasmids. Proc Natl Acad Sci USA 97 (2000) 6108-6113
14. Chen H.L., Subbarao K., Swayne D., Chen Q., and Lu X.H. Generation and evaluation of a high-growth reassortant H9N2 influenza A virus as a vaccine candidate. Vaccine 21 (2003) 1983-1988
15. Lu X., Tumpey T.M., Morken T., Zaki S.R., Cox N.J., and Katz J.M. A mouse model for the evaluation of pathogenesis and immunity to influenza A (H5N1) viruses isolated from humans. J Virol 73 (1999) 5903-5911
16. Tian G., Zhang S., Li Y., Bu Z., Liu P., Zhou J., et al. Protective efficacy in chickens, geese and ducks of an H5N1-inactivated vaccine developed by reverse genetics. Virology 3341 (2005) 153-162
17. Garcia-Sastre A., and Palese P. Genetic manipulation of negative-strand RNA virus genomes. Annu Rev Microbiol 47 (1993) 765-790
18. Fodor E., Devenish L., Engelhardt O.G., Palese P., Brownlee G.G., and García-Sastre A. Rescue of influenza A virus from recombinant DNA. J Virol 73 (1999) 9679-9682
19. Neumann G., Watanabe T., Ito H., Watanabe S., Goto H., Gao P., et al. Generation of influenza A viruses entirely from cloned cDNAs. Proc Natl Acad Sci USA 96 (1999) 9345-9350
20. Lipatov A.S., Webby R.J., Govorkova E.A., Krauss S., and Webster R.G. Efficacy of H5 influenza vaccines produced by reverse genetics in a lethal mouse model. J Infect Dis 191 (2005) 1216-1220
21. Marsh G.A., and Tannock G.A. The role of reverse genetics in the development of vaccines against respiratory viruses. Expert Opin Biol Ther 5 (2005) 369-380
22. Nicolson C., Major D., Wood J.M., and Robertson J.S. Generation of influenza vaccine viruses on Vero cells by reverse genetics: an H5N1 candidate vaccine strain produced under a quality system. Vaccine 23 (2005) 2943-2952
23. Webby R.J., Perez D.R., Coleman J.S., Guan Y., Knight J.H., Govorkova E.A., et al. Responsiveness to a pandemic alert: use of reverse genetics for rapid development of influenza vaccines. Lancet 363 (2004) 1099-1103
24. Liu M., Wood J.M., Ellis T., Krauss S., Seiler P., Johnson C., et al. Preparation of a standardized, efficacious agricultural H5N3 vaccine by reverse genetics. Virology 314 (2003) 580-590
25. Webster R.G., Webby R.J., Hoffmann E., Rodenberg J., Kumar M., Chu H.J., et al. The immunogenicity and efficacy against H5N1 challenge of reverse genetics-derived H5N3 influenza vaccine in ducks and chickens. Virology 351 (2006) 303-311
26. Katz JM, Garg S, Sambhara S. Influenza vaccines: current and future strategies. In: Kawaoka Y, editor, Influenza virology: current topics. England; 2006. p. 216.
27. Kawaoka Y., Krauss S., and Webster R.G. Avian to human transmission of the PB1 gene of influenza A virus in the 1957 and 1968 pandemics. J Virol 63 (1989) 4603-4608